Abstract:
The invention relates to fatty acid soap bar compositions comprising flat platy particles wherein the particles individually have deposition system (i.e., cationic polymers and anionic surfactant) on them.
Abstract:
The invention relates to non-aqueous personal wash compositions comprising little or no surfactant but which utilize a foam enhancing system to generate good levels of foam.
Abstract:
Improved deposition and low rub-off compositions are described. The compositions are emulsions with aqueous-based film-forming resins in the water phase and particle with hydrophobic material in the oil phase of the emulsion. The compositions are low rub-off after being topically applied.
Abstract:
The invention described herein relates to novel genes and their encoded proteins, termed Mutants Associated with Resistance to STI-571 (e.g., T315I Bcr-Abl), and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express MARS. The invention further provides methods for identifying molecules that bind to and/or modulate the functional activity of MARS.
Abstract:
The invention relates to soap-based liquid body and facial wash compositions using high solvent, low water compositions and incompletely neutralized fatty acids to help structure the compositions, all in combination with modified benefit agents, enhanced deposition of antimicrobial agents is obtained.
Abstract:
The present invention relates to mutant BCR-ABL kinase proteins, and to diagnostic and therapeutic methods and compositions useful in the management of disorders, for example cancers, involving cells that express such mutant BCR-ABL kinase proteins.
Abstract:
The invention described herein relates to novel genes and their encoded proteins, termed Mutants Associated with Resistance to STI-571 (e.g., T315I Bcr-Abl), and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express MARS. The invention further provides methods for identifying molecules that bind to and/or modulate the functional activity of MARS.
Abstract:
The invention relates to novel bar compositions comprising complexes formed from interaction of multivalent ions and soap. The insoluble complexes permit greater solid contents which counterintuitively, enhance lather (i.e., even if soluble soap is complexed, it is believed more can be used). Further, the complexes enhance rate of wear, hardness, mildness and deposition. The invention further comprises process for enhancing benefits by adding multivalent ions to soap stock during processing.
Abstract:
The present invention comprises novel bar compositions comprising relatively high levels of soap and of filler while maintaining good user properties.
Abstract:
The invention described herein relates to novel genes and their encoded proteins, termed Mutants Associated with Resistance to STI-571 (e.g., T315I Bcr-Abl), and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express MARS. The invention further provides methods for identifying molecules that bind to and/or modulate the functional activity of MARS.